Recurrent pregnancy loss (RPL) affects approximately 1–2% of couples and has traditionally focused on maternal causes. Increasing evidence recognises the male partner’s contribution, notably through ...
Dietary quality in early-onset gastrointestinal malignancies: NHANES 2005-2018. Impact of consensus molecular subtyping (CMS) on survival in the CO.26 trial of durvalumab plus tremelimumab versus best ...
Circulating tumor cells as a biomarker for monitoring: Disease progression, treatment response, and minimal residual disease. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results